Latest information on COVID-19
Support teaching, research, and patient care.
I am interested in the technology and applications of Magnetic Resonance Imaging (MRI). I have ongoing research projects involving the basic technology of MRI (e.g. insertable gradient coils and RF components), biophysical measurements using MR (e.g., combined T1 and T2 mapping using efficient imaging sequences), basic science applications of MR (e.g., in-vivo detection rare cell populations using MRI and the use of MR to longitudinally monitor tumor growth deep within tissue starting from a single cell), and clinical applications, especially in cardiovascular disease. I am presently interested in developing and using in-vivo ultra-high field (e.g. 7 Tesla) Magnetic Resonance techniques to study important human diseases. The increased sensitivity and enhanced contrast mechanisms at these high magnetic field strengths should provide insight to unsolved problems, especially in neuroscience and cancer.
High-Field MRI Iron-Based Contrast-Enhanced Characterization of Multiple Sclerosis and Demyelinating Diseases
Feraheme (ferumoxytol) is FDA-approved for iron supplementation and is composed of iron oxide
nanoparticles classified among the ultra-small superparamagnetic iron oxides (USPIO). In this
project we hypothesize that Feraheme could become a sensitive and specific marker of active
inflammation in multiple sclerosis. We will explore this hypothesis taking advantage of ultra
high field strength (7T) MRI to further increase the effectiveness of the contrast agent
Feraheme at revealing inflammatory activity.
Stanford is currently not accepting patients for this trial.
For more information, please contact SPECTRUM, .
View full details